By Milana Vinn and Anirban Sen
(Reuters) -Evolent Health is in talks with private equity firms and other companies for a potential sale, in a process that kicked off after the healthcare services provider received inbound interest, people familiar with the matter said on Thursday.
Private equity firms TPG, CD&R and KKR are among the parties that have expressed interest in a deal for Evolent, which has a market value of $3.3 billion, the sources said. TPG was one of the early investors in Evolent.
Health insurer Elevance Health is also among the bidders and could team up with a private equity firm to acquire Evolent, the sources added.
Evolent, TPG, CD&R, KKR and Elevance did not immediately respond to requests for comment.
Evolent, which is working with a financial adviser on the sale process, has received initial bids, the sources said. They added that a deal could be reached in the next few weeks.
The sources, who requested anonymity as the discussions are confidential, cautioned that a deal may not materialize.
(Reporting by Milana Vinn and Anirban Sen in New York; Editing by Paritosh Bansal)
Comments